KR970032884A - Immunostimulators for the Treatment and Prevention of Livestock Diseases - Google Patents

Immunostimulators for the Treatment and Prevention of Livestock Diseases Download PDF

Info

Publication number
KR970032884A
KR970032884A KR1019950048433A KR19950048433A KR970032884A KR 970032884 A KR970032884 A KR 970032884A KR 1019950048433 A KR1019950048433 A KR 1019950048433A KR 19950048433 A KR19950048433 A KR 19950048433A KR 970032884 A KR970032884 A KR 970032884A
Authority
KR
South Korea
Prior art keywords
purified protein
protective agent
immunostimulators
prevention
treatment
Prior art date
Application number
KR1019950048433A
Other languages
Korean (ko)
Other versions
KR0179338B1 (en
Inventor
김종만
우승룡
조윤상
Original Assignee
김광희
농촌진흥청
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 김광희, 농촌진흥청 filed Critical 김광희
Priority to KR1019950048433A priority Critical patent/KR0179338B1/en
Publication of KR970032884A publication Critical patent/KR970032884A/en
Application granted granted Critical
Publication of KR0179338B1 publication Critical patent/KR0179338B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/085—Staphylococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/099—Bordetella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
    • Y02A40/70—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in livestock or poultry

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

본 발명은 포도상 구균(Staphylococcus aureus cowan I주)의 사(死)균제 또는 정제 단백질; 그리고 보데텔라균(Bordetella pertussis ATCC 9797)의 정제 단백질을 유효성분으로, 그리고 보호제를 함유함을 특징으로 하는 동물용 면역증강제를 제공한다. 이 면역증강제는 각종의 세균성 질병에 대해 면역증강 효과를 나타낼 뿐만 아니라 바이러스 질병에 대해서도 우수한 면역효과를 나타낸다.The present invention is a fungal or purified protein of Staphylococcus aureus cowan I strain; And it provides an animal immunopotentiator characterized in that it contains purified protein of Bodetella pertussis ATCC 9797 as an active ingredient and a protective agent. This adjuvant not only exerts an immune enhancing effect against various bacterial diseases but also shows an excellent immune effect against viral diseases.

Description

가축질병의 치료 및 예방을 위한 면역증강제Immunostimulators for the Treatment and Prevention of Livestock Diseases

본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음Since this is an open matter, no full text was included.

Claims (3)

포도상 구균(Staphylococcus aureus cowan I주)의 사(死) 균체 또는 정제 단백질:그리고 보데텔라균(Bordetella pertussis ATCC 9797)의 정제 단백질을 유효성분으로, 그리고 보호제를함유함 특징으로 하는 동물용 면역증강제.4 cells or purified protein of Staphylococcus aureus cowan I: and an animal immunopotentiator characterized by containing purified protein of Bodetella pertussis ATCC 9797 as an active ingredient and a protective agent. 제 1항에 있어서, 보호제는 약 10%탈지분유(skim milk)임을 특징으로 하는 면역 증강제.2. The immune enhancer of claim 1 wherein the protective agent is about 10% skim milk. 제 1항에 있어서, 증류수에 레바미졸(Levamisole, sigma, 500ug/ml)이 들어있는 희석액을 이용하여㎖당 1mg의 증강제가 함유되도록 녹여서 사용하는 것을 특징으로 하는 면역증강제.2. The immunopotentiator according to claim 1, wherein the diluent containing levamisole (Levamisole, sigma, 500 ug / ml) is dissolved in distilled water to contain 1 mg of an enhancer per ml. ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.※ Note: The disclosure is based on the initial application.
KR1019950048433A 1995-12-11 1995-12-11 Immunostimulator KR0179338B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019950048433A KR0179338B1 (en) 1995-12-11 1995-12-11 Immunostimulator

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019950048433A KR0179338B1 (en) 1995-12-11 1995-12-11 Immunostimulator

Publications (2)

Publication Number Publication Date
KR970032884A true KR970032884A (en) 1997-07-22
KR0179338B1 KR0179338B1 (en) 1999-03-20

Family

ID=19439104

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019950048433A KR0179338B1 (en) 1995-12-11 1995-12-11 Immunostimulator

Country Status (1)

Country Link
KR (1) KR0179338B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20210069843A (en) 2019-12-04 2021-06-14 하용수 Improval materials for preventing disease of animal

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101304983B1 (en) * 2011-09-16 2013-09-05 녹십자수의약품(주) Composition for immune enhancement and immunity enhancing method using the same

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20210069843A (en) 2019-12-04 2021-06-14 하용수 Improval materials for preventing disease of animal

Also Published As

Publication number Publication date
KR0179338B1 (en) 1999-03-20

Similar Documents

Publication Publication Date Title
WO2000034265A3 (en) Quinoline-indole antimicrobial agents
WO1995017165A3 (en) Tissue moisturizing and antimicrobial compositions
NO996269L (en) Quinoline-indole antimicrobial agents, as well as the use and mixtures thereof
ATE316794T1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING LYSOSTAPHIN ALONE OR IN COMBINATION WITH AN ANTIBIOTIC FOR THE TREATMENT OF STAPHYLOCOCCAL INFECTIONS
KR950031099A (en) Lactic acid bacteria-containing sakha drug composition
ZA947957B (en) Substituted 1-naphthyl-3-pyrazolecarboxamides which are active in neurotensin their preparation and pharmaceutical compositions containing them
WO2000000214A3 (en) Pharmaceutical preparations for use in combatting or preventing surface infections caused by microorganisms
WO2002005642A3 (en) Synergistic biocidal compositions
BR9712141A (en) Application of 1-hyphroxy-2-pyridones to treat skin infections.
BR8804710A (en) COMPOSITIONS CONTAINING BIO-SYNTHETIC PESTICIDES PRODUCTS, AND PROCESSES FOR THE MANUFACTURE OF THE SAME AND TO ELIMINATE INSECTS
WO1999067238A3 (en) Tetrahydroquinoline-indole derivatives antimicrobial agents, their uses and compositions containing them
KR970032884A (en) Immunostimulators for the Treatment and Prevention of Livestock Diseases
CA2213794A1 (en) Preventive or therapeutic drug for alzheimer's disease
CA2072047A1 (en) Pharmaceutical compositions
BR9815339A (en) Fungicidal and / or bactericidal composition, process to control phytopathogenic fungi or bacteria in a medium, combating process, as a curative or preventive, phytopathogenic fungi in cultures and / or bacteria and product
YU155791A (en) ANTIPROLIFERATIVE SUBSTITUTED TRICYCLIC COMPOUNDS
NO944246L (en) Halogenated 4'-methoxyacetophenones such as microbicides and preservatives
FR2700268B1 (en) Cosmetic or pharmaceutical composition, especially dermatological, containing an extract of Vismia.
BE900186A (en) SYNERGISTIC FUNGICIDE COMPOSITIONS.
JPS5742627A (en) Prophylactic against infection
Oh et al. Isolation and identification of growth inhibition substance on L. monocytogenes from Dystaenia takesimana Kitagawa
KR920011469A (en) Oral composition
KR940011006A (en) Periodontal disease prevention and therapeutic composition comprising golden extract as an active ingredient
KR960703512A (en) Germicidal Composition for Agiricultural / Horticultural Use
SU1069820A1 (en) Antiseptic agent "tubercupolisine"

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
EXPY Expiration of term